SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-15-000957
Filing Date
2015-03-23
Accepted
2015-03-23 07:32:08
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1516444.htm 20-F 3655941
2 EXHIBIT 4.17 exhibit_4-17.htm EX-4.17 529449
3 EXHIBIT 4.37 exhibit_4-37.htm EX-4.37 18715
4 EXHIBIT 4.38 exhibit_4-38.htm EX-4.38 556409
5 EXHIBIT 4.39 exhibit_4-39.htm EX-4.39 257747
6 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 20455
7 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 20086
8 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 5385
9 EXHIBIT 13.2 exhibit_13-2.htm EX-13.1 5512
10 EXHIBIT 15.5 exhibit_15-5.htm EX-15.5 5040
11 pwc.jpg GRAPHIC 3663
12 pp2.jpg GRAPHIC 63643
13 omega.jpg GRAPHIC 40210
14 logo.jpg GRAPHIC 6765
  Complete submission text file 0001178913-15-000957.txt   5233747
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-35223 | Film No.: 15717676
SIC: 2834 Pharmaceutical Preparations